Institute of Liver Diseases, Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine, 528 Zhangheng Road, Shanghai 201203, China.
J Ethnopharmacol. 2013 Jul 9;148(2):691-700. doi: 10.1016/j.jep.2013.05.031. Epub 2013 May 22.
Fuzheng Huayu recipe (FZHY) was formulated on the basis of Chinese medicine theory in treating liver fibrosis. It has a significant efficacy against liver fibrosis caused by chronic hepatitis B, with the action mechanisms of inhibition of hepatic stellate cell activation, protection of hepatocyte oxidative injury and regulations of hepatic matrix remodeling etc.
To identify the absorbed components and metabolites of Danshen in FZHY in rat serum, and find their active components for anti-liver fibrosis.
A valid high performance liquid chromatography-electrospray ionization ion trap mass spectrometry (HPLC-ESI/MS(n)) method was established to investigate the absorbed and metabolized compounds of Danshen in FZHY in rat serum after oral administration. Mass spectra were acquired in both negative and positive modes. Otherwise, to evaluate the anti-hepatic fibrosis efficacies of absorbed and metabolized compounds, the LX-2 cell line of hepatic stellate cell (HSC), which was crucial cellular basis of fibrogenesis, was cultured and incubated with absorbed compounds, the cytotoxicity was determined with the cellomics Multiparameter Cytotoxicity Kit 1 by High Content Screening (HCS), the cell proliferation was assayed with EdU-DNA incorporation, and the cell activation was analyzed through α-smooth muscle actin (α-SMA) expression with high content screening technology.
More than 11 compounds and 2 metabolites from Danshen were identified in the serum after oral administration of FZHY by comparing their mass spectra and retention behavior with reference compounds or literature data. Among these compounds, there were no obvious changes in nuclear morphology, membrane permeability with blow 96 μM of six polar compounds treatment in comparison with control cells, respectively. And the salvianolic acid B (6 μM, 48 μM), caffeic acid (6 μM, 48 μM) and rosmarinic acid (48 μM) could obviously inhibit LX-2 cells proliferation, down-regulate α-SMA expression.
The results proved that the established method could be applied to analyze the absorbed into blood compounds of Danshen after oral administration FZHY. These absorbed compounds included 11 compounds and 2 metabolites of Danshen. Among them, the salvianolic acid B, caffeic acid and rosmarinic acid were the effective components of FZHY to anti-hepatic fibrosis effects.
扶正化瘀方(FZHY)是基于中医理论治疗肝纤维化的方剂。它对慢性乙型肝炎引起的肝纤维化有显著疗效,其作用机制包括抑制肝星状细胞激活、保护肝细胞氧化损伤和调节肝基质重塑等。
鉴定 FZHY 中丹参在大鼠血清中的吸收成分和代谢产物,并寻找其抗肝纤维化的活性成分。
建立了一种有效的高效液相色谱-电喷雾电离阱质谱(HPLC-ESI/MS(n))方法,用于研究口服 FZHY 后丹参在大鼠血清中的吸收和代谢化合物。质谱在正负模式下均被采集。此外,为了评估吸收和代谢化合物的抗肝纤维化功效,培养肝星状细胞(HSC)的 LX-2 细胞系,这是纤维化的关键细胞基础,并与吸收化合物孵育,用细胞分析多参数细胞毒性试剂盒 1 通过高内涵筛选(HCS)测定细胞毒性,用 EdU-DNA 掺入法测定细胞增殖,用高内涵筛选技术分析 α-平滑肌肌动蛋白(α-SMA)表达分析细胞激活。
通过比较其质谱和保留行为与对照化合物或文献数据,从 FZHY 口服给药后的血清中鉴定出 11 种以上的化合物和 2 种代谢产物。在这些化合物中,与对照细胞相比,分别用 96 μM 的 6 种极性化合物处理后,核形态和膜通透性均无明显变化。而丹酚酸 B(6 μM、48 μM)、咖啡酸(6 μM、48 μM)和迷迭香酸(48 μM)能明显抑制 LX-2 细胞增殖,下调 α-SMA 表达。
结果证明,所建立的方法可用于分析口服 FZHY 后丹参入血的化合物。这些吸收的化合物包括丹参的 11 种化合物和 2 种代谢产物。其中,丹酚酸 B、咖啡酸和迷迭香酸是 FZHY 抗肝纤维化作用的有效成分。